Mining Gut Microbiota From Bariatric Surgery for MAFLD

The progression of metabolic dysfunction associated fatty liver disease (MAFLD) leads to steatohepatitis, liver fibrosis and hepatocellular carcinoma. Thus far, there have been no FDA-approved medications for MAFLD. Bariatric surgery (BS) has been found to improve insulin resistance, steatohepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wei-Kai, Chen, Yi-Hsun, Lee, Po-Chu, Yang, Po-Jen, Chang, Chin-Chen, Liu, Kao-Lang, Hsu, Cheng-Chih, Huang, Chi-Chang, Chuang, Hsiao-Li, Sheen, Lee-Yan, Liu, Chun-Jen, Wu, Ming-Shiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063105/
https://www.ncbi.nlm.nih.gov/pubmed/33897617
http://dx.doi.org/10.3389/fendo.2021.612946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063105/
https://www.ncbi.nlm.nih.gov/pubmed/33897617
http://dx.doi.org/10.3389/fendo.2021.612946

Ejemplares similares